Evidence map›Paper›PMID 41691311›Full record

ArticleJournal of medical case reports2026

Naproxen as a cause of acute cholestatic hepatitis: a case report.

Cautar El Maimouni, Natalia Jiménez-Esquivel, Alejandra Duarte, Alba Díaz, M Carmen Salgado, Xavier Forns, Enric Reverter

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cautar El MaimouniLiver and Digestive ICU, Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
Natalia Jiménez-EsquivelLiver and Digestive ICU, Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
Alejandra DuarteInternal Medicine Department, Hospital de Barcelona, Barcelona, Spain.
Alba DíazPathology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
M Carmen SalgadoBiochemistry Department, Hospital Clinic de Barcelona, Barcelona, Spain.
Xavier FornsLiver and Digestive ICU, Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
Enric ReverterLiver and Digestive ICU, Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain. ereverte@clinic.cat.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDrug-induced liver injury is a common cause of acute liver injury and acute liver failure worldwide, and nonsteroidal antiinflammatory drugs are the third most common pharmaceutical group related with its development. Between nonsteroidal antiinflammatory drugs, naproxen is a propionic derivate widely used and generally safe drug. CASE PRESENTATION: We present an 83 year-old Caucasian male patient with cholestatic acute liver injury secondary to naproxen with associated cholemic nephropathy and atrioventricular block during admission. The patient was managed with one session of plasma exchange, forced diuresis, ursodeoxycholic acid, and a short course of corticosteroids.

conclusionGiven the rarity of this phenomenon, we report this case to support the limited evidence available, particularly in the light of the widespread and routine utilization of nonsteroidal antiinflammatory drugs by a significant proportion of the population.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalChemical and Drug Induced Liver InjuryCholestasisNaproxenAged, 80 and overAtrioventricular BlockHumansMalePlasma ExchangeTreatment OutcomeUrsodeoxycholic AcidAnti-Inflammatory Agents, Non-SteroidalNaproxenUrsodeoxycholic AcidCholemic nephropathyDrug-induced liver injuryNaproxenNSAIDs

Identifiers

PMID41691311
PMCPMC13011533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.